Sell-side analysts and investors visit Hikma Casablanca site
London, 14 November 2024 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, is today hosting sell-side analysts and investors at its offices and manufacturing facility in Casablanca, Morocco.
The visit will provide the opportunity for attendees to tour our facility, including our new sterile injectables plant, which is nearing completion. Senior members of the Middle East and North Africa (MENA) team will also present on our Branded and MENA Injectables businesses, our strategy and how we are uniquely placed to continue to deliver profitable growth in the region. No new material information will be provided.
The presentation is available on Hikma’s website at https://www.hikma.com/investors/results-and-presentations/. A recording and transcript of the presentation and Q&A will be made available following the event.